UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005775
Receipt number R000006824
Scientific Title Assessment of efficacy and safety of ezetimibe in patients with dyslipidemia complicated insulin resistance.
Date of disclosure of the study information 2011/06/20
Last modified on 2019/12/25 12:42:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Assessment of efficacy and safety of ezetimibe in patients with dyslipidemia complicated insulin resistance.

Acronym

Assessment of efficacy and safety of ezetimibe in patients with dyslipidemia complicated insulin resistance.

Scientific Title

Assessment of efficacy and safety of ezetimibe in patients with dyslipidemia complicated insulin resistance.

Scientific Title:Acronym

Assessment of efficacy and safety of ezetimibe in patients with dyslipidemia complicated insulin resistance.

Region

Japan


Condition

Condition

Dyslipidemia complicated insulin resistance

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The effect of the improvement on the insulin resistance and the internal organs obesity and the fatty liver of Ezetimib for the patients with dyslipidemia complicated insulin resistance is clarified.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

1)Flow Mediated Dilation test
2)Volume of visceral fat and fatty liver)
3)Improvement ratio of Cholesterol Absorption and Synthesis Markers
4)Improvement ratio of Oxidized low density lipoprotein and Atherogenic lipoprotein level
3)

Key secondary outcomes

1)Improvement ratio of glucose metabolism makers
2)Improvement of inflammatory makers and Oxidation makers


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Take Ezetimib:10mg/day for 12 months.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)LDL-C>=120mg/dL
2)Patients not change drug therapy for anti-dyslipidemic and/or anti-diabetic agent within 12weeks of the study entry.
3)HOMA-IR>=2.5 or BMI>=25

Key exclusion criteria

1)HbA1c>=8%
2)Patients with anamnesis for anaphylaxis of ezetimibe tablets
3)Complicated with Severe renal and/or hepatic disease
4)Having anamnesis of myocardial infarction, angina and/or stroke
5)Patients with secondary hyperlipidemia or drug-associated hyperlipidemia
6)Patients who are pregnant or lactating women and women suspected of being pregnant
7)Patients of Familial hyperlipidemia
8)Other patients deemed not appropriate for study entry by the investigator.

Target sample size

70


Research contact person

Name of lead principal investigator

1st name Odawara
Middle name
Last name Masato

Organization

Tokyo Medical University

Division name

The Department of Diabetes, Endocrinology and Metabolism

Zip code

1600023

Address

6-7-1 Nishi Shinjuku, Shinjuku-ku, Tokyo 160-0023

TEL

03-3342-6111

Email

odawara@tokyo-med.ac.jp


Public contact

Name of contact person

1st name Miwa
Middle name
Last name Takashi

Organization

Tokyo Medical University

Division name

The Department of Diabetes, Endocrinology and Metabolism

Zip code

1600023

Address

6-7-1 Nishi Shinjuku, Shinjuku-ku, Tokyo 160-0023

TEL

03-3342-6111

Homepage URL


Email

miwa-t@tokyo-med.ac.jp


Sponsor or person

Institute

The Department of Diabetes, Endocrinology and Metabolism, Tokyo Medical University Hospital

Institute

Department

Personal name



Funding Source

Organization

The Department of Diabetes, Endocrinology and Metabolism, Tokyo Medical University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Medical University

Address

6-1-1 Shinjuku, Shinjuku-ku, Tokyo

Tel

0333426111

Email

kenkyu-s@tokyo-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京医科大学病院


Other administrative information

Date of disclosure of the study information

2011 Year 06 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

47

Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

Because paper is being submitted.

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 12 Month 28 Day

Date of IRB

2013 Year 10 Month 30 Day

Anticipated trial start date

2010 Year 05 Month 01 Day

Last follow-up date

2012 Year 03 Month 01 Day

Date of closure to data entry

2012 Year 04 Month 01 Day

Date trial data considered complete

2012 Year 04 Month 01 Day

Date analysis concluded

2012 Year 08 Month 01 Day


Other

Other related information



Management information

Registered date

2011 Year 06 Month 14 Day

Last modified on

2019 Year 12 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006824


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name